Catalyst Wire Dossier Catalyst Wire Dossier

Bioven

intravenous immunoglobulin · Biopharma Plasma LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Bioven, covering 2020-10-14 to 2024-09-23. Get the full timeline:

Most recent: Clinical Trial Update: Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in Adults [Phase 3]

See pricing